0001971360-23-000001.txt : 20230404 0001971360-23-000001.hdr.sgml : 20230404 20230404113900 ACCESSION NUMBER: 0001971360-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230404 DATE AS OF CHANGE: 20230404 EFFECTIVENESS DATE: 20230404 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Immunaeon Inc. CENTRAL INDEX KEY: 0001971360 IRS NUMBER: 834283805 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-477830 FILM NUMBER: 23795866 BUSINESS ADDRESS: STREET 1: 701 ELLICOTT STREET CITY: BUFFALO STATE: NY ZIP: 14203 BUSINESS PHONE: 716-336-6543 MAIL ADDRESS: STREET 1: 701 ELLICOTT STREET CITY: BUFFALO STATE: NY ZIP: 14203 D 1 primary_doc.xml X0708 D LIVE 0001971360 Immunaeon Inc. 701 ELLICOTT STREET BUFFALO NY NEW YORK 14203 716-336-6543 NEW YORK None None Corporation true 2018 Adam Utley 64 Dorchester Road Buffalo NY NEW YORK 14222 Executive Officer Chief Executive Officer Joseph Dinardo 3301 NE 1st Street LPH 4 Miami FL FLORIDA 33137 Executive Officer Director of Growth Daniel Rera 12 Briar Hill Road Orchard Park NY NEW YORK 14127 Executive Officer Chief Operating Officer Biotechnology $1 - $1,000,000 06b false 2023-02-23 false true true Simple Agreement for Future Equity false 5000 Indefinite 250000 Indefinite false 1 0 0 100000 true The proceeds will be used for general operating capital, including operational infrastructure, marketing, and salaries. The above estimate includes the salaries of executive officers for a two-year period. false Immunaeon Inc. /Adam Utley/ Adam Utler CEO 2023-03-29